UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Y
Number of items: 196.

A

Adeyemo, D; Imtiaz, F; Toffa, S; Lowdell, M; Winslet, M; (2000) Bax/Bcl-2 ratio is elevated by combines 5FU and antioxidant in colon cancer cells in vitro. GUT , 46 A54 - A54.

Adeyemo, D; Toffa, S; Lowdell, M; Winslet, M; (2000) 5 ASA upregulates 5FU induced Bax expression in colon cancer cells in vitro. BRIT J CANCER , 83 58 - 58.

Adeyemo, D; Toffa, S; Lowdell, M; Winslet, M; (2000) Antioxidants augment 5FU upregulation of Bax expression in colon cancer cells in vitro. BRIT J CANCER , 83 58 - 58.

Ahmed, F; Watts, MJ; Ings, SJ; Flynn, M; Linch, DC; (2000) Poor viability of freshly apheresed PBSC harvests: Implications for overnight storage before cryopreservation or additional manipulative procedures. BLOOD , 96 (11) 380A - 380A.

Allen, AJR; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2000) Lack of pathogenic mutations in the 5 ' UTR of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. BLOOD , 96 (11) 742A - 742A.

Allford, SL; Harrison, P; Lawrie, AS; Cohen, H; Mackie, IJ; Machin, SJ; (2000) Recurrent thrombotic thrombocytopenic purpura: Association of durable remission with cyclosporin and recovery in vWF-cleaving protease activity. Presented at: UNSPECIFIED.

Allford, SL; Harrison, P; Lawrie, AS; Liesner, R; Mackie, IJ; Machin, SJ; (2000) von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. British Journal of Haematology , 111 (4) pp. 1215-1222. 10.1046/j.1365-2141.2000.02503.x.

Allford, SL; Harrison, P; Lawrie, AS; Liesner, R; Mackie, IJ; Machin, SJ; (2000) von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 111 (4) 1215 - 1222.

Almeida, A; Mehta, A; (2000) Malaria and Anaemia. Postgraduate Doctor (Caribbean) , 16 (9) pp. 392-394.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, IM; Linch, DC; (2000) Mutations in ELA2 encoding for neutrophil elastase are a frequent finding in sporadic but not familial severe congenital neutropenia. BLOOD , 96 (11) 445A - 445A.

Anderson, L; Porter, JB; Wonke, B; Walker, JM; Holden, S; Davis, BA; Prescott, E; ... Pennell, DJ; + view all (2000) Cardiac iron deposition is not predicted by conventional markers of iron overload in homozygous beta-thalassaemia. BLOOD , 96 (11) 606A - +.

Anderson, L; Porter, JB; Wonke, B; Walker, JM; Holden, S; Davis, BA; Prescott, E; ... Pennell, DJ; + view all (2000) Relationship of myocardial iron overload to right and left ventricular function in homozygous beta-thalassemia. BLOOD , 96 (11) 605A - +.

Anderson, LJ; Holden, S; Davis, BA; Prescott, E; Charrier, C; Bunce, NH; Firmin, DN; ... Pennell, DJ; + view all (2000) A novel method of cardiac iron measurement using magnetic resonance T2*imaging in thalassemia: Validation and clinical application. CIRCULATION , 102 (18) 403 - 403.

Anderson, R; Macdonald, I; Corbett, T; Whiteway, A; Prentice, HG; (2000) A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction. Journal of Virological Methods , 85 (1-2) pp. 23-34. 10.1016/S0166-0934(99)00150-0.

Ardeshna, KM; Corney, CP; Ings, SJ; Watts, MJ; Linch, DC; Devereux, S; (2000) A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34(+) progenitors. VOX SANG , 79 (1) 46 - 52.

Ardeshna, KM; Pizzey, AR; Devereaux, S; Khwaja, A; (2000) The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. BLOOD , 96 (3) 1039 - 1046.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Orr, S; Linch, DC; Devereux, S; (2000) Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction. BRIT J HAEMATOL , 108 (4) 817 - 824.

Ardeshna, KM; Walker, SJ; Devereux, S; Linch, DC; Khwaja, A; (2000) The p38 stress activated protein kinase mediates the increased responsiveness of mature dendritic cells to macrophage inhibitory protein 3 beta (MIP3 beta) and secondary lymphoid chemokine (SLC). BLOOD , 96 (11) 33A - 33A.

Ardeshna, KM; Walker, SJ; Devereux, S; Linch, DC; Khwaja, A; (2000) The p38 stress activated protein kinase mediates the increased responsiveness of mature dendritic cells to macrophage inhibitory protein 3β (mip3β) and secondary lymphoid chemokine (slc). Blood , 96 (11 PART )

Arnold, J; Cohen, H; (2000) Heparin-induced skin necrosis. British journal of haematology , 111 992-.

Ashford, P; Gozzard, D; Jones, J; Revill, J; Wallis, J; Bruce, M; Chapman, J; ... British Committee for Standards in Haematology Blood Transfusion, F; + view all (2000) Guidelines for blood bank computing. Transfusion medicine , 10 pp. 307-314.

Aubert, G; Dodi, A; Koh, M; Grace, S; Potter, M; Prentice, G; Travers, P; (2000) Monitoring of cytomegalovirus antigen specific T cells in post bone marrow transplant patients. Human Immunology , 61 (Suppl)

B

Baker, RJ; Hart, SM; Mehta, AB; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Ross, DD; (2000) Expression of breast cancer resistance protein (BCRP) in malignant cells from patients with B-chronic lymphocytic leukaemia (B-CLL) and acute lymphoblastic leukemia (ALL). BLOOD , 96 (11) 824A - 824A.

Baugh, M; Gavrilovic, J; Davies, JR; Williams, T; Hughes, DA; Sampson, MJ; (2000) Monocyte matrix metalloproteinase production in Type 2 diabetes and controls. Presented at: UNSPECIFIED.

Berger, LA; Warwick, R; Mehta, A; (2000) Isolated candida infection of the pterygoid muscles in a patient with Gauchers disease. American Journal of Rentgenology , 176 1332-.

Bodmer, JG; Bodmer, WF; Marsh, SGE; (2000) HLA Nomenclature: The Name of the Rose. In: Lecher, R and Warrens, A, (eds.) HLA and Disease. (pp. 147-161). Academic Press: London.

Borthwick, NJ; Lowdell, M; Salmon, M; Akbar, AN; (2000) Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis. INT IMMUNOL , 12 (7) 1005 - 1013.

Botchway, ANS; Flores, NA; Sheridan, DJ; Cohen, H; (2000) Storage pool defect in pooled huffy coat platelet concentrates within the shelf-life period. CLIN LAB HAEMATOL , 22 (1) 21 - 27.

Brady, CS; Bartholomew, JS; Burt, DJ; Duggan-Keen, MF; Glenville, S; Telford, N; Little, AM; ... Stern, PL; + view all (2000) Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens , 55 (5) pp. 401-411.

C

Chakrabarti, S; Kottaridis, P; Ogormon, P; Peggs, K; Osman, H; Chopra, R; Mackinnon, S; (2000) High incidence of early and late CMV infection and delayed immune reconstitution after allogeneic transplants with nonmyeloablative conditioning using Campath (anti-CD52 antibody). In: BLOOD. (pp. 586A - +). AMER SOC HEMATOLOGY

Chakraverty, R; McMillan,, AK; Chopra, R; Goldstone, AH; (2000) High dose therapy for the treatment of non-Hodgkin's lymphoma. In: Armitage, JO and Antman, KH, (eds.) High Dose Cancer Therapy. Williams and Wilkins

Chakraverty, R; Robinson, S; Peggs, K; Kottaridis, P; Watts, M; Ings, S; Hale, G; ... Mackinnon, S; + view all (2000) Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation. In: BLOOD. (pp. 587A - +). AMER SOC HEMATOLOGY

Chatterjee, R; Andrews, HO; McGarrigle, HH; Kottaridis, PD; Lees, WR; Mackinnon, S; Ralph, DJ; (2000) Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemoradiotherapy for haematological malignancies. BONE MARROW TRANSPL , 25 (11) 1185 - 1189.

Chatterjee, R; Gemidjioglu, ME; Davis, BA; Helal, MA; Cullum, I; Porter, JB; (2000) Longitudinal evaluation of the contribution of hypogonadism to the severity of osteoporosis in homozygous beta-thalassemia. BLOOD , 96 (11) 23B - 23B.

Chatterjee, R; Kottaridis, PD; Lees, WR; Ralph, DJ; Goldstone, AH; (2000) Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma. LANCET LTD

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Mackinnon, S; Goldstone, AH; (2000) Patterns of Leydig cell insufficiency in adults following bone marrow transplantation for hematological malignancies. BLOOD , 96 (11) 403A - 403A.

Chilcott, IT; Margara, R; Cohen, H; Rai, R; Skull, J; Pickering, W; Regan, L; (2000) Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. FERTIL STERIL , 73 (3) 526 - 530.

Chopra, R; Eaton, JD; Grassi, A; Potter, M; Shaw, B; Salat, C; Neumeister, P; ... Barbui, T; + view all (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol , 111 (4) pp. 1122-1129.

Clark, R; Byatt, SA; Bennett, CF; Brama, M; Martineau, M; Moorman, AV; Roberts, K; ... Harrison, CJ; + view all (2000) Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. LEUKEMIA , 14 (2) pp. 241-246. 10.1038/sj.leu.2401654.

Codrington, R; O'Connor, HE; Jalali, GR; Carrara, P; Papaioannou, M; Hart, SM; Hoffbrand, AV; ... Foroni, L; + view all (2000) Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value. BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1071-1079. 10.1046/j.1365-2141.2000.02464.x.

Cohen, H; Love, E; Williamson, L; Jones, H; (2000) Serious hazards of transfusion: a scheme for haemovigilance. Presented at: 28th world congress of the international society of haematology, Toronto.

Corell, A; Pay, AL; Little, AM; Hoddinott, MA; Arguello, JR; Borton, M; Dunne, C; ... Marsh, SGE; + view all (2000) Reference strand mediated conformation analysis resolves HLB-DRB1 typing ambiguities when matching for unrelated bone marrow transplantation. TISSUE ANTIGENS , 56 (1) pp. 82-86. 10.1034/j.1399-0039.2000.560111.x.

Cox, ST; Hossain, E; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*8202 identified in a Caucasoid potential bone marrow donor. Tissue Antigens , 56 (2) pp. 188-191.

Cox, ST; Little, AM; Madrigal, JA; Marsh, SGE; (2000) Sequence of HLA-A*0209 confirmed. IMMUNOGENETICS , 51 (6) pp. 489-490. 10.1007/s002510050648.

Cox, ST; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor. Tissue Antigens , 55 (2) pp. 185-187.

Cunningham, D; Mainwaring, PN; Gregory, W; Hoskin, P; Hancock, B; Smith, P; Hudson, GV; (2000) Mitoxantrone is superior to doxorubicin in a multi-agent weekly regimen for patients with high-grade lymphoma over the age of 60 years: Results of a BNLI randomised trial of PACEBO vs. British Journal of Cancer , 83 (Su 1-.

D

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; Hindmarsh, PC; ... Robinson, ICAF; + view all (2000) Molecular genetics of septo-optic dysplasia. HORMONE RESEARCH , 53 26 - 33.

Davis, BA; O'Sullivan, C; Eliahoo, J; Jarritt, P; Porter, JB; (2000) Long-term prognostic value of serial measurement of ventricular function in the management of homozygous beta-thalassemia. BLOOD , 96 (11) 23B - 23B.

Davis, BA; Porter, JB; (2000) Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. BLOOD , 95 (4) 1229 - 1236.

Diaz, RM; Bateman, A; Emiliusen, L; Fielding, A; Trono, D; Russell, SJ; Vile, RG; (2000) A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. GENE THERAPY , 7 (19) pp. 1656-1663. 10.1038/sj.gt.3301277.

Dodi, IA; Morgan, CL; Madrigal, JA; (2000) The significance of HLA matching in cord blood stem cell transplantation. In: Cohen, SBA and Gluckman, E and Rubinstein, P and Madrigal, JA, (eds.) Cord Blood Transplantation. (pp. 205-238). Martin Dunitz Ltd: London.

Donohoe, S; Kingdom, JCP; Mackie, IJ; Burrell, S; Quenby, S; Jauniaux, E; Machin, SJ; (2000) Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. THROMB HAEMOSTASIS , 84 (1) 32 - 38.

Donohoe, S; Kingdom, JCP; Mackie, IJ; Burrell, S; Quenby, S; Jauniaux, E; Machin, SJ; (2000) Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Thrombosis and Haemostasis , 84 (1) pp. 32-38.

Duke, V; Kapoor, A; Gricks, C; Melo, J; Foroni, L; (2000) BCL10 deletions in haematological malignancies: a cloning artefact? BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1106-1108. 10.1046/j.1365-2141.2000.02447.x.

E

Eren, E; Travers, PJ; (2000) The molecular structure of the major histocompatibility complex and its molecular interactions. In: Lechler, R and Warrens, A, (eds.) HLA in Health and Disease. Academic Press

F

Farquharson, MJ; Bagshaw, AP; Porter, JB; Abeysinghe, RD; (2000) The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload. PHYS MED BIOL , 45 (5) 1387 - 1396.

Fielding, AK; Chapel-Fernandes, S; Chadwick, MP; Bullough, FJ; Cosset, FL; Russell, SJ; (2000) A hyperfusogenic gibbon ape leukemia envelope glycoprotein: Targeting of a cytotoxic gene by ligand display. HUMAN GENE THERAPY , 11 (6) pp. 817-826. 10.1089/10430340050015437.

Fischer, G; Arguello, JR; Perez-Rodriguez, M; McWhinnie, A; Marsh, SGE; Travers, PJ; Madrigal, JA; (2000) Sequence-specific oligonucleotide probing for MICB alleles reveals associations with MICA and HLA-B. IMMUNOGENETICS , 51 (7) pp. 591-599. 10.1007/s002510000179.

Flores, NA; Botchway, ANS; Turner, MA; Cohen, H; Sheridan, DJ; (2000) Products of the platelet release reaction accentuate the ischaemia-induced reduction in action potential duration (APD(95)) in the isolated perfused guinea-pig heart. In: J PHYSIOL-LONDON. (pp. 111P - 112P). CAMBRIDGE UNIV PRESS

Flores, NA; Botchway, ANS; Turner, MA; Cohen, H; Sheridan, DJ; (2000) Products of the platelet release reaction influence cardiac electrophysiology independently of platelet-platelet interactions. PLATELETS , 11 (7) 415 - 417.

G

Gardiner, C; Mackie, IJ; Machin, SJ; (2000) Evaluation of a new automated latex particle immunoassay for D-dimer: IL test D-dimer. Laboratory Hematology , 6 (3) pp. 147-150.

Gardiner, C; Mackie, IJ; Malia, RG; Jones, DW; Winter, M; Leeming, D; Taberner, DA; ... Greaves, M; + view all (2000) The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant. BRIT J HAEMATOL , 111 (4) 1230 - 1235.

Gascoigne, NRJ; Alam, SM; Lin, CM; McGuire, MV; Marine, S; Niederberger, N; Redpath, S; ... Zal, T; + view all (2000) T cell receptor binding kinetics and special role of V alpha in T cell development and activation. Immunologic Research , 21 (2-3) pp. 225-231.

Greaves, M; Cohen, H; Machin, SJ; Mackie, I; (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. BRIT J HAEMATOL , 109 (4) 704 - 715.

Greene, JN; Linch, DC; Miller, CB; (2000) Current treatments for infection in neutropenic patients with hematologic malignancy. Oncology (Williston Park) , 14 (8 Suppl ) pp. 31-34.

Gudi, M; Hasserjian, R; Gomez, K; Abboudi, Z; Kaczmarski, R; Szydlo, R; Lampert, I; (2000) Prognostic factors in high grade non-hodgkin's lymphomas in the elderly. Blood , 96 (11 PART )

H

Hart, SM; Ganeshaguru, K; Mehta, A; (2000) Multi-drug resistance in haematological malignancies. CME Bulletin Haematology , 3 (1) pp. 6-8.

Harvey, CJ; Peniket, AJ; Miszkiel, K; Patterson, K; Goldstone, AH; Mackinnon, S; Hall-Craggs, MA; (2000) MR angiographic diagnosis of cerebral venous sinus thrombosis following allogeneic bone marrow transplantation. BONE MARROW TRANSPLANTATION , 25 (7) pp. 791-795. 10.1038/sj.bmt.1702238.

Helmberg, W; Hegland, J; Hurley, CK; Maiers, M; Marsh, SGE; Muller, C; Rozemuller, EH; (2000) Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. TISSUE ANTIGENS , 56 (1) pp. 99-102. 10.1034/j.1399-0039.2000.560115.x.

Hoddinott, MA; Cox, ST; McWhinnie, AJ; Marsh, SGE; Ogilvie, H; Madrigal, JA; Little, AM; (2000) A new allele, HLA-B*1555, identified in an African patient awaiting bone marrow transplantation. TISSUE ANTIGENS , 55 (5) pp. 463-466. 10.1034/j.1399-0039.2000.550512.x.

J

Jackson, A; Carrara, P; Duke, V; Sinclair, P; Papaioannou, M; Harrison, CJ; Foroni, L; (2000) Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Research , 60 (11) pp. 2775-2779.

Jackson, TR; Brown, FD; Nie, ZZ; Miura, K; Foroni, L; Sun, JL; Hsu, VW; ... Randazzo, PA; + view all (2000) ACAPs are Arf6 GTPase-activating proteins that function in the cell periphery. JOURNAL OF CELL BIOLOGY , 151 (3) pp. 627-638. 10.1083/jcb.151.3.627.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Ganeshaguru, K; (2000) Enchancement of the TNF-related apoptis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents. BLOOD , 96 (Abstr) 79a-.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Ganeshaguru, K; (2000) Enhancment of TNF-related apoptosis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents. BLOOD , 96 (11) 79A - 79A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (2000) Activation of caspase 8 in the absence of FAS ligation in the killing of B-CLL cells by cytotoxic drugs and radiation. British Journal of Haematology , 108 (Abstr) 72-.

Jones, DW; Gallimore, MJ; Mackie, IJ; Harris, SL; Winter, M; (2000) Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. BRIT J HAEMATOL , 110 (3) 721 - 726.

Jones, DW; Mackie, IJ; Gallimore, MJ; Winter, M; (2000) Are antibodies to coagulation factor XII a risk factor for recurrent fetal loss? BLOOD , 96 (11) 269A - 269A.

K

Kelly, PF; Vandergriff, J; Nathwani, A; Nienhuis, AW; Vanin, EF; (2000) Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. BLOOD , 96 (4) 1206 - 1214.

Kenneally, A; Liang, B; Barber, LD; (2000) The peptide-binding motif of HLA-B*3505. Immunogenetics , 51 (10) pp. 866-868.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (2000) Alloantigen-specific T cell depletion: From the bench to the bedside via a murine model. Hematology and Cell Therapy , 42 (2-3) pp. 187-190.

Kottaridis, PD; Gale, RE; Frew, ME; Harrison, G; Langabeer, SE; Belton, AA; Walker, H; ... Linch, DC; + view all (2000) The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials. BLOOD , 96 (11) 825A - 825A.

Kottaridis, PD; Milligan, DW; Chopra, R; Chakraverty, RK; Chakrabarti, S; Robinson, S; Peggs, K; ... Mackinnon, S; + view all (2000) In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. BLOOD , 96 (7) 2419 - 2425.

Kottaridis, PD; Milligan, DW; Mahendra, P; Chopra, R; Chakraverty, R; Chakrabarti, S; Peggs, K; ... UK Collaborative Study, ; + view all (2000) Non-myeloablative conditioning limits transplant related mortality in patients who have previously failed high dose treatment. In: BLOOD. (pp. 553A - +). AMER SOC HEMATOLOGY

Kottaridis, PD; Peggs, K; Devereux, S; Goldstone, AH; Mackinnon, S; (2000) Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation. HAEMATOLOGICA , 85 (10) 1116 - 1117. Gold open access

Kottaridis, PD; Peggs, K; Lawrence, A; Verfuerth, S; Chatterjee, R; Telfer, P; Porter, JB; ... Goldstone, AH; + view all (2000) One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders. BONE MARROW TRANSPL , 25 (6) 677 - 678.

L

Lalancette, M; Michallet, M; Szydlo, R; Rezvani, K; Mackinnon, S; Blaise, D; Finke, J; ... Apperley, J; + view all (2000) The importance of patient selection in non-myeloablative stem cell transplant (NMSCT) for acute and chronic leukemia, myelodysplastic syndrome, and myeloma. BLOOD , 96 (11) 199A - 199A.

Lalancette, M; Rezvani, K; Szydlo, R; Mackinnon, S; Juliusson, G; Michallet, M; Slavin, S; ... Apperley, J; + view all (2000) Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience. BLOOD , 96 (11) 204A - 204A.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2000) Mutations in the AML1 gene in acute myeloid leukaemia patients with FAB types M0 and M7. BLOOD , 96 (11) 698A - 698A.

Langabeer, SE; Gale, RE; Walker, H; Linch, DC; (2000) Reported cryptic rearrangements of CBF beta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA. LEUKEMIA , 14 (5) 944 - 945.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2000) Effect of instruments on lupus anticoagulant testing - Rebuttal. THROMB HAEMOSTASIS , 83 (2) 346 - 348.

Linch, DC; Gosden, RG; Tulandi, T; Tan, S-L; Hancock, SL; (2000) Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Hematology Am Soc Hematol Educ Program pp. 205-221. Gold open access

Linch, DC; Smith, P; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, D; ... Gregory, WM; + view all (2000) A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma. ANNALS OF ONCOLOGY , 11 87 - 90.

Linch, DC; Smith, P; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, D; ... Gregory, WM; + view all (2000) A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma. Ann Oncol , 11 Sup pp. 87-90.

Loreal, O; Gosriwatana, I; Guyader, D; Porter, J; Brissot, P; Hider, RC; (2000) Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. JOURNAL OF HEPATOLOGY , 32 (5) pp. 727-733. 10.1016/S0168-8278(00)80240-8.

Love, EM; Cohen, H; Williamson, LM; Hilary, J; (2000) Haemovigilance in the UK: What have the first three years of the serious hazards of transfusion scheme (SHOT) achieved? TRANSFUSION , 40 (10) 44S - 45S.

Love, EM; Williamson, L; Cohen, H; Jones, H; (2000) The 1998/1999 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Lowdell, MW; (2000) Autologous leukaemia-reactive cd8+ nk cells are required for long-term survival after treatment for acute leukaemia. Blood , 96 (11 PART )

Lowdell, MW; Koh, MBC; (2000) Immunotherapy of AML: future directions. J CLIN PATHOL , 53 (1) 49 - 54.

Lowdell, MW; Wood, ME; Samuel, D; Craston, R; Saha, V; Prentice, HG; (2000) Autologous leukaemia-reactive CD8+NK cells are required for long-term survival after treatment for acute leukaemia. BLOOD , 96 (11) 119A - 119A.

M

Macdonald, C; Walker, S; Watts, M; Ings, S; Linch, DC; Devereux, S; (2000) Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: Implications for gene therapy. HUM GENE THER , 11 (4) 587 - 595.

Mackinnon, S; (2000) Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation? BRIT J HAEMATOL , 110 (1) 12 - 17.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; ... Pay, AL; + view all (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. BLOOD , 96 (11) 1792-.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; ... Pay, AL; + view all (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. BLOOD , 96 (11) 417A - 417A.

Mallett, SV; Peachey, TD; Sanehi, O; Hazlehurst, G; Mehta, A; (2000) Reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. ANAESTHESIA , 55 (10) pp. 1013-1019. 10.1046/j.1365-2044.2000.01618-3.x.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. Hum Immunol , 61 (8) pp. 841-842.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. WHO Nomenclature Committee for Factors of HLA System. Tissue Antigens , 56 (3) pp. 286-288.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update December 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (4) pp. 381-382.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 61 (6) 630-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (6) pp. 571-572.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update January 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (5) pp. 475-476.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for Factors of the HLA system. Hum Immunol , 61 (9) 950-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for factor of HLA System. Tissue Antigens , 56 (3) pp. 289-290.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update March 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (1) pp. 103-104.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (2) pp. 191-194.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 61 (3) pp. 354-356.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update August 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 563-564.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update October 2000. Hum Immunol , 61 (12) pp. 1404-1405.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. Hum Immunol , 61 (12) 1403-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 565-566.

Marsh, SGE; (2000) Nomenclature for factors of HLA system, update August 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1055-1056. 10.1016/S0198-8859(00)00204-4.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update April/May 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (4) pp. 251-252. 10.1046/j.1365-2370.2000.00229.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) p. 109. 10.1046/j.1365-2370.2000.00207.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. HUMAN IMMUNOLOGY , 61 (4) pp. 425-426. 10.1016/S0198-8859(00)00102-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. TISSUE ANTIGENS , 55 (6) pp. 571-572.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. HUMAN IMMUNOLOGY , 61 (6) p. 630. 10.1016/S0198-8859(00)00134-8.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 161. 10.1046/j.1365-2370.2000.00219.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) pp. 159-160. 10.1046/j.1365-2370.2000.00210.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. HUMAN IMMUNOLOGY , 61 (5) pp. 528-529. 10.1016/S0198-8859(00)00116-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) pp. 433-434.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1053-1054. 10.1016/S0198-8859(00)00205-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update June 2000. HUMAN IMMUNOLOGY , 61 (9) p. 950. 10.1016/S0198-8859(00)00169-5.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update June 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) p. 431.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update March 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 163. 10.1046/j.1365-2370.2000.00224.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update October/November 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) pp. 105-107. 10.1046/j.1365-2370.2000.00208.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update September 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (1) p. 55. 10.1046/j.1365-2370.2000.00201.x.

Marsh, SGE; Parham, P; Barber, L; (2000) The HLA Factsbook. [Book]. Academic Press

McGreavey, L; Fallen, PR; Ethel, M; Potter, M; Prentice, HG; Travers, PJ; Madrigal, JA; (2000) Analysis of reconstitution the T-cell compartment in patients undergoing stem cell transplantation. Human Immunology , 61 (Suppl) 497A-.

Mehta, A; Mason, PJ; Vulliamy, TJ; (2000) Glucose-6-phosphate dehydrogenase deficiency. Best Practice and Research Clinical Haematology , 13 (1) pp. 21-38. 10.1053/beha.1999.0055.

Mehta, AB; Hoffbrand, AV; (2000) Haematology at a Glance. [Book]. Blackwell Science: Oxford.

Meja, KK; Seldon, PM; Nasuhara, Y; Ito, K; Barnes, PJ; Lindsay, MA; Giembycz, MA; (2000) p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br J Pharmacol , 131 (6) pp. 1143-1153. 10.1038/sj.bjp.0703684.

Mills, AK; Goldstone, AH; Linch, DC; Peggs, KS; Kyriakou, C; Mackinnon, S; (2000) Long-term follow-up of allogeneic bone marrow transplants for lymphoma: The case for conventional conditioning regimens. In: BLOOD. (pp. 392A - 392A). AMER SOC HEMATOLOGY

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Forum: journal club. Cytometry , 42 (6) pp. 394-395.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Simplified flow cytometric method for fetal hemoglobin containing red blood cells. CYTOMETRY , 42 (6) 389 - 393.

N

Nathwani, AC; Hanawa, H; Vandergriff, J; Kelly, P; Vanin, EF; Nienhuis, AW; (2000) Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Therapy , 7 (3) pp. 183-195.

Nitu-Whalley, IC; Lee, CA; Griffioen, A; Jenkins, PV; Pasi, KJ; (2000) Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. BRIT J HAEMATOL , 108 (2) 259 - 264.

Noble, KE; Harkness, D; Yong, KL; (2000) Interleukin 10 regulates cellular responses in monocyte/endothelial cell co-cultures. BRIT J HAEMATOL , 108 (3) 497 - 504.

O

O'Neil, E; Wickremasinghe, RG; Jackson, T; Grant Prentice, H; Lowdell, MW; (2000) CDSαon human natural killer cells may act as a costimulatory molecule. Blood , 96 (11 PART )

O'Neil, E; Wickremasinghe, RG; Jackson, T; Prentice, HG; Lowdell, MW; (2000) CD8 alpha on human natural killer cells may act as a costimulatory molecule. In: BLOOD. (pp. 43B - 43B). AMER SOC HEMATOLOGY

Orchard, KH; Cooper, MS; Wijdenes, J; Borchardt, P; Quadri, SM; Buscombe, JR; Hilson, AJ; ... Prentice, HG; + view all (2000) Pre-clinical evaluation of candidate antibodies for targeted radiotherapy for patients with multiple myeloma. Journal of Nuclear Medicine , 41 (5) 463-.

Orchard, KH; Cooper, MS; Wijdenes, J; Borchardt, P; Quadri, SM; Buscombe, JR; Hilson, AJ; ... Prentice, HG; + view all (2000) Pre-clinical evaluation of candidate antibodies for targeted radiotherapy for patients with multiple myeloma. J NUCL MED , 41 (5) 117P - 118P.

Orleans-Lindsay, JK; Prentice, HG; Lowdell, MW; (2000) Acute myleoid leukemia cells induce T cell but not NK cell unresponsiveness - Implications for the adoptive immunotherapy of leukemia. BLOOD , 96 (11) 116A - 116A.

P

Pang, KF; Ganeshaguru, K; Hart, SM; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; (2000) Gene expression of multidrug resistant protein (MRP) homologues in B-CLL and AML cells. British Journal of Haematology , 108 71-.

Paterson, PJ; Marshall, SR; Shaw, B; Kendra, JR; Ethel, M; Kibbler, CC; Prentice, HG; (2000) Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. Bone Marrow Transplantation , 26 (6) pp. 701-703.

Peggs, KS; Ings, SJ; Kottaridis, PD; Yong, K; Williams, CD; Goldstone, AH; Mackinnon, S; (2000) Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring. BLOOD , 96 (1) 369 - 370.

Peggs, KS; Mahendra, P; Milligan, DW; Chopra, R; Chakraverty, RK; Kottaridis, PD; Chakrabarti, S; ... UK Collaborative Grp, ; + view all (2000) Non-myeloablative transplantation using matched unrelated donors - In vivo CAMPATH-1H limits graft versus host disease. In: BLOOD. (pp. 841A - 841A). AMER SOC HEMATOLOGY

Peggs, KS; Preiser, W; Kottaridis, PD; McKeag, N; Brink, NS; Tedder, RS; Goldstone, AH; ... Mackinnon, S; + view all (2000) Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation. BRIT J HAEMATOL , 111 (3) 782 - 790.

Peggs, KS; Verfuerth, S; Khan, N; Moss, PAH; Mackinnon, S; (2000) Massive in vivo expansion of CMV-specific T-cells following adoptive transfer post allogeneic transplantation: Quantitation using HLA-peptide tetramers and T-cell receptor (TCR) spectratyping. In: BLOOD. (pp. 586A - +). AMER SOC HEMATOLOGY

Peggs, KS; Williams, CD; Chopra, R; D'Sa, S; Thuraisundaram, D; Schey, S; Craddock, C; ... UK Collaborative Study, ; + view all (2000) Non-myeloablative allogeneic transplantation with adjuvant dose escalated donor lymphocyte infusions for multiple myeloma. BLOOD , 96 (11) 781A - 781A.

Perez-Rodriguez, M; Corell, A; Arguello, JR; Cox, ST; McWhinnie, A; Marsh, SGE; Madrigal, JA; (2000) A new MICA allele with ten alanine residues in the exon 5 microsatellite. TISSUE ANTIGENS , 55 (2) pp. 162-165. 10.1034/j.1399-0039.2000.550209.x.

Porter, JC; Spiro, SG; (2000) Detection of early lung cancer. Thorax , 55 Sup S56-S62. 10.1136/thorax.55.suppl_1.s56.

R

Ramon, D; Scott, I; Cox, ST; Pesoa, S; Vullo, C; Little, AM; Madrigal, JA; (2000) HLA-A*6817, identified in the Kolla Amerindians of North-West Argentina possesses a novel nucleotide substitution. Tissue Antigens , 55 (5) pp. 453-454.

Rezvani, K; Lalancette, M; Szydlo, R; Mackinnon, S; Blaise, D; Slavin, S; Alessandrino, EP; ... Frassoni, F; + view all (2000) Non-myeloablative stem cell transplant (NMSCT) in AML, ALL, and MDS: Disappointing outcome for patients with advanced phase disease. BLOOD , 96 (11) 479A - 479A.

Rioja, A; Pizzey, AR; Marson, CM; Thomas, NSB; (2000) Preferential induction of apoptosis of leukaemic cells by farnesol. FEBS LETT , 467 (2-3) 291 - 295.

Robertson, JD; Gale, RE; Wynn, RF; Dougal, M; Linch, DC; Testa, NG; Chopra, R; (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. British Journal of Haematology , 109 (2) pp. 272-279. 10.1046/j.1365-2141.2000.01970.x.

Robertson, JD; Gale, RE; Wynn, RF; Dougal, M; Linch, DC; Testa, NG; Chopra, R; (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. BRIT J HAEMATOL , 109 (2) 272 - 279.

Robinson, J; Malik, A; Parham, P; Bodmer, JG; Marsh, SGE; (2000) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. TISSUE ANTIGENS , 55 (3) pp. 280-287. 10.1034/j.1399-0039.2000.550314.x.

Robinson, J; Marsh, SG; (2000) The IMGT/HLA sequence database. Rev Immunogenet , 2 (4) pp. 518-531.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2000) In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. BRIT J HAEMATOL , 108 (4) 859 - 864.

Robinson, MSC; Mackie, IJ; Machin, SJ; Harrison, P; (2000) Two colour analysis of reticulated platelets. CLIN LAB HAEMATOL , 22 (4) 211 - 213.

Robinson, SP; Addada, J; Green, N; Wong, WL; Shaw, P; Chakraverty, R; Goldstone, AH; ... Linch, DC; + view all (2000) Response to short course ESHAP chemotherapy in relapsed and refractory lymphoma. BLOOD , 96 (11) 246B - 246B.

Robinson, SP; Mackinnon, S; Goldstone, AH; Slavin, S; Carella, AM; Russell, N; Taghipour, G; ... EBMT, ; + view all (2000) Higher than expected transplant-related mortality and relapse following nonmyeloablative stem cell transplantation for lymphoma adversely effects progression free survival. BLOOD , 96 (11) 554A - +.

Ruiz, M; Giudicelli, V; Ginestoux, C; Stoehr, P; Robinson, J; Bodmer, J; Marsh, SGE; ... Lefranc, MP; + view all (2000) IMGT, the international ImMunoGeneTics database. NUCLEIC ACIDS RESEARCH , 28 (1) pp. 219-221. 10.1093/nar/28.1.219. Gold open access

S

Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA; (2000) Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS , 14 (8) 1001 - 1007.

Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA; (2000) Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS , 14 (8) pp. 1001-1007.

Shephard, EA; Janmohamed, A; Hernandez, D; McCombie, PR; Bootman, MA; Dolphin, CT; Smith, RL; ... Phillips, IR; + view all (2000) 13th International Symposium on Microsomes and Drug Oxidations. In: (Proceedings) Flavin-containing monooxygenases. : Stresa, Italy.

Shoab, SS; Porter, JB; Scurr, JH; Coleridge-Smith, PD; (2000) Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study. J VASC SURG , 31 (3) 456 - 461.

Side, LE; Peniket, AJ; Levy, ER; Williamson, H; Humphray, SJ; Langabeer, SE; Walker, H; ... Wainscoat, JS; + view all (2000) Molecular characterization of the chromosome 9q deletion in AML. BLOOD , 96 (11) 542A - 542A.

Somervaille, TCP; Linch, DC; Khwaja, A; (2000) Survival signalling in primary human erythroblasts occurs through PI3-kinase/Akt/GSK3 and not the classical MAP kinase pathway. BLOOD , 96 (11) 79A - 79A.

Sud, R; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2000) Mutations in the TGF beta RII gene are unlikely to be responsible for the reduced sensitivity to TGF beta in megakaryocytes from patients with essential thrombocythaemia. BLOOD , 96 (11) 743A - 743A.

Swerdlow, AJ; Barber, JA; Hudson, GV; Cunningham, D; Gupta, RK; Hancock, BW; Horwich, A; ... Linch, DC; + view all (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. Journal of Clinical Oncology , 18 (3) pp. 498-509.

Swerdlow, AJ; Barber, JA; Hudson, GV; Cunningham, D; Gupta, RK; Hancock, BW; Horwich, A; ... Linch, DC; + view all (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J CLIN ONCOL , 18 (3) 498 - 509.

T

Tatton, L; Chopra, R; Khwaja, A; (2000) The selective Src kinase inhibitor PP1 also inhibits c-kit and Bcr-Abl tyrosine kinases and induces apoptosis in mast cell leukaemia, CML and AML cells. BLOOD , 96 (11) 81A - 81A.

Taylor, CPF; Mehta, AB; (2000) Infusional 5-fluorouracil in cutaneous leukaemia: A novel palliative therapy in haematological malignancy. Hematology , 5 (3) pp. 205-207.

Towers, G; Bock, M; Martin, S; Takeuchi, Y; Stoye, JP; Danos, O; (2000) A conserved mechanism of retrovirus restriction in mammals. P NATL ACAD SCI USA , 97 (22) 12295 - 12299.

V

Verfuerth, S; Peggs, K; Mackinnon, S; (2000) A versatile culture system for the in vitro expansion of autologous donor-derived cytomegalovirus, Epstein Barr virus and Aspergillus antigen-specific T cells. In: BLOOD. (pp. 27A - 27A). AMER SOC HEMATOLOGY

Verfuerth, S; Peggs, K; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S; (2000) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. BLOOD , 95 (12) 3990 - 3995.

Virchis, AE; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; Prentice, HG; Wickremasinghe, RG; (2000) A role for C-ABL tyrosine kinase in p53 upregulation and apoptosis in B-CLL cells exposed to chlorambucil. BLOOD , 96 (Abstr) 82a-.

Virchis, AE; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; Prentice, HG; Wickremasinghe, RG; (2000) A role for c-Abl tyrosine kinase in p53 upregulation and apoptosis in B-CLL cells exposed to chlorambucil. BLOOD , 96 (11) 82A - 82A.

W

Watts, MJ; Ings, SJ; Flynn, M; Dodds, D; Goldstone, AH; Linch, DC; (2000) Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. BRIT J HAEMATOL , 111 (1) 287 - 291.

Watts, MJ; Ings, SJ; Leverett, D; MacMillan, A; Devereux, S; Goldstone, AH; Linch, DC; (2000) ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients. BRIT J CANCER , 82 (2) 278 - 282.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2000) Variable product purity and functional capacity after CD34+cell selection: A comparison of the CliniMACS and Isolex 300i clinical scale devices. BLOOD , 96 (11) 773A - 773A.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Glen, TA; Prentice, HG; Hoffbrand, AV; Mehta, AB; (2000) The AKT protein kinase mediates plasma-induced survival of B-CLL cells. British Journal of Haematology , 108 (Abstr) 72-.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lewin, J; Prentice, HG; Hoffbrand, AV; Mehta, AB; (2000) Increases in cytoplasmic cytochrome c is not a rate-limiting step in the induction of apoptosis of B-CLL cells. British Journal of Haematology , 108 (Abstr) 72-.

Williamson, L; Cohen, H; Love, E; Jones, H; Todd, A; Soldan, K; (2000) The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox sanguinis , 78 Sup pp. 291-295.

Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; (2000) Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. BRIT J CLIN PHARMACO , 49 (3) 231 - 239.

Y

Yee, TT; Griffioen, A; Sabin, CA; Dusheiko, G; Lee, CA; (2000) The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. GUT , 47 (6) 845 - 851.

This list was generated on Sun May 26 05:06:31 2019 BST.